Financial Implications in Management of Multidrug Resistant Tuberculosis in India
Journal: International Journal of Science and Research (IJSR) (Vol.6, No. 1)Publication Date: 2017-01-05
Authors : Jairaj P Nair; Amita U Athavale; Vijay S Khatri; Tanjul Saxena;
Page : 535-539
Keywords : Economical; Resources; funding; Cost; Expensive;
Abstract
Aim To calculate total cost incurred by patients for Multi-drug Resistant Tuberculosis (MDR-TB) management and evaluate their financial resources. Financial details regarding MDR-TB management were collected from 30 patients. Average daily drugs cost was Rs.166.83. Average family monthly income was Rs.8333.33. Average Per Capita Income was Rs.1473.67. Financial help for treatment was provided by self-funding, relatives, socio-religious groups, hospital supply& stockists. Total cost of MDR-TB management is Rs.140752.50. Including sensitive first line MDR-TB drugs reduces cost remarkably.90 % of the study group belonged to economically productive age group. Institutional treatment is the cheapest mode.
Other Latest Articles
- Incidence of Postdural Puncture Headache in Patients Undergoing Lower Segment Ceasserian Section
- Clinical Hand Off (Transfer of Care): A Plea for Human Factor Engineering
- Spurious High Platelet Count by Automated Hematology Analyzer in Patient with Microcytic RBCS
- Effect of Obesity on Psychological Profile of Adolescents
- Physiological studies of Helminthosporium Pathovars Isolated from Infected Maize Plant in the Region of Karnataka
Last modified: 2021-06-30 17:35:27